An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. People who received antithymocyte globulin had similar C ...
Cytokine release syndrome occurred in 33 and 24% of participants in the ATG 2.5- and 0.5mg/kg groups, respectively, and in no participants in the placebo group. HealthDay News — Antithymocyte globulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results